For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Richard Medlicott
Richard Medlicott

Richard Medlicott is a specialist GP in Wellington and a long-time champion of good use of IT in healthcare
Articles by Richard Medlicott
Article archive
How to Treat
Wednesday 28 May 2025, 12:50 AM
Latest news
10/06/2025
06/06/2025